Toxic epidermal necrolysis associated with denileukin diftitox (DAB389IL-2) administration in a patient with follicular large cell lymphoma.
about
Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity.Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.Life-threatening dermatologic adverse events in oncologyAnticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.
P2860
Toxic epidermal necrolysis associated with denileukin diftitox (DAB389IL-2) administration in a patient with follicular large cell lymphoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Toxic epidermal necrolysis ass ...... ollicular large cell lymphoma.
@en
Toxic epidermal necrolysis associated with denileukin diftitox
@nl
type
label
Toxic epidermal necrolysis ass ...... ollicular large cell lymphoma.
@en
Toxic epidermal necrolysis associated with denileukin diftitox
@nl
prefLabel
Toxic epidermal necrolysis ass ...... ollicular large cell lymphoma.
@en
Toxic epidermal necrolysis associated with denileukin diftitox
@nl
P2093
P2860
P1433
P1476
Toxic epidermal necrolysis ass ...... ollicular large cell lymphoma.
@en
P2093
Abdul H Diwan
Aleksandar Jankov
Ann T Tong
Chiyu Wang
Donald Parks
Kristel Polder
Madeleine Duvic
Nam H Dang
Pamela L Walker
P2860
P304
P356
10.1080/10428190500233764
P577
2005-12-01T00:00:00Z